Industry leaders David Thompson, Charlie Buckwell and Alison Doughty will help Kudos build on current momentum
Kudos, the platform for showcasing research, has today announced a series of high-profile appointments that significantly strengthen the company’s position as it builds momentum in the life sciences sector. The appointments reflect the company’s expanded focus on enabling pharmaceutical and biotechnology organisations to communicate research more transparently and reach audiences more effectively.
Left to right: David Thompson, Charlie Buckwell, Alison Doughty
Joining the Kudos Board are David Thompson and Charlie Buckwell, both highly respected leaders with deep experience across life sciences, healthcare innovation, growth strategy and investment. David Thompson has led major, global pharma services businesses, including his tenure as CEO of Envision Pharma Group; his current roles include several advisory and board positions across AI-healthcare and medical communications companies. Charlie Buckwell, having started his career within prominent pharmaceutical companies, including AstraZeneca, was Chief Executive of McCann Health Medical Communications and subsequently Chief Medical Communications Officer at IPG Health. Charlie is now engaged on a growing portfolio of advisory and non-executive roles across life sciences, healthcare and med-tech businesses.
Kudos has also appointed Alison Doughty as an advisor to the company. Alison brings extensive experience across healthcare communications, commercial growth and strategic development, having led businesses including Inspired Science, part of Omnicom, and 90TEN, part of Envision; Alison’s current role is as an advisor and consultant to several innovative health-tech companies.
David, Charlie and Alison’s combined expertise and industry relationships will propel Kudos’ expansion into the pharma and biotech markets, strengthening the company’s long-term vision, and creating new commercial opportunities and strategic partnerships.
Fraser Macleod, Managing Director at Kudos, says, “we are delighted to welcome Alison, Charlie, and David to the Kudos team. Their combined experience and guidance - together with their enthusiasm for Kudos’ potential will be invaluable as we rapidly scale-up and succeed in this next phase of growth.”
Kudos co-founder Melinda Kenneway is now stepping down from the board and will be replaced by co-founder Charlie Rapple. Co-founder David Sommer continues on the board along with Chair Alison Forrestal.
— ENDS —
Contact:
Charlie Rapple
charlie@growkudos.com
About Kudos
Kudos (growkudos.com) is the platform for showcasing research, helping more people find, understand and use it. Over 650,000 researchers use Kudos to bring science to life through the power of storytelling. Kudos is the only toolkit designed specifically to drive research communications, engagement and impact, helping researchers cross boundaries, achieve more influence, and gain more recognition.
